- Country: Russia
- Summary: Supply of Medicinal Products for Medical Use with the International Nonproprietary Name "Polypeptides of the Cerebral Cortex of Cattle", "Hydroxyzine", "Alimemazine"
- RUT Ref No: 105876203
- Deadline: 21 Aug 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 774400.00
- Notice Type: Tender
- Document Ref. No.: 0841200000724001500
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply of medicinal products for medical use with the international nonproprietary name "Polypeptides of the cerebral cortex of cattle", "Hydroxyzine", "Alimemazine"
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of Medicinal Products for Medical Use with the International Nonproprietary Name "Polypeptides of the Cerebral Cortex of Cattle", "Hydroxyzine", "Alimemazine" - Russia Tender
The REGIONAL STATE PUBLIC INSTITUTION "GOVERNMENT PURCHASING AGENCY OF THE KOSTROMA REGION, a Government sector organization in Russia, has announced a new tender for Supply of Medicinal Products for Medical Use with the International Nonproprietary Name "Polypeptides of the Cerebral Cortex of Cattle", "Hydroxyzine", "Alimemazine". This tender is published on RussiaTenders under RUT Ref No: 105876203 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-08-21.
The estimated tender value is RUB 774400.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
